Pfizer Inc 2017 AR2
The report highlights Pfizer's 2017 performance, focusing on its 'Four Imperatives': innovation, capital allocation, corporate responsibility, and culture. The company achieved 10 FDA product approvals and advanced 43 pipeline assets. Key sustainability efforts included progress toward 2020 environmental goals, reducing greenhouse gas emissions by 3.7% and waste by 7% compared to 2016. Pfizer also emphasized its commitment to the UN Sustainable Development Goals, particularly Goal 3, through initiatives like Access Accelerated and the donation of millions of doses of medicines for trachoma and opioid overdose.
Company: Pfizer Inc
Sector: Health Care
Country: United States
Year: 2017
Type: AR2
Pages: 158
Pfizer Inc
Annual Review
The report highlights Pfizer's 2017 performance, focusing on its 'Four Imperatives': innovation, capital allocation, corporate responsibility, and culture. The company achieved 10 FDA product approvals and advanced 43 pipeline assets. Key sustainability efforts included progress toward 2020 environmental goals, reducing greenhouse gas emissions by 3.7% and waste by 7% compared to 2016. Pfizer also emphasized its commitment to the UN Sustainable Development Goals, particularly Goal 3, through initiatives like Access Accelerated and the donation of millions of doses of medicines for trachoma and opioid overdose.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2017
Reporting Period
Jan 1, 2017 - Dec 31, 2017
Fiscal Year
2017
Published
Mar 12, 2018
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Water Consumption
Total Waste
Employees